Allon granted US patent for composition of matter
Allon Therapeutics Inc. announced that it has been granted a US patent covering additional composition of matter for the products in the ADNP platform, which broadens the intellectual property of Allon's patent portfolio. Gordon McCauley, President and CEO of Allon, said these claims provide further independent validation of the unique and important nature of these highly novel neuroprotective peptides.
The allowed claims relate to the nucleic acid composition of Allon's drug candidates AL-108 and AL-208, which are both currently being evaluated in Phase II human efficacy trials. The Company has three Phase II clinical efficacy programs. AL-108 is being evaluated in two separate trials, one for Alzheimer's disease and another for schizophrenia related cognitive impairment. AL-208 is being evaluated as a treatment for the mild cognitive impairment associated with coronary artery bypass graft (MCI-CABG) surgery.
Topics
Organizations
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Promise of cost-effective healthcare delivery to boost remote patient monitoring market, says Frost & Sullivan - Benefits include customised care in home-settings and reduced public healthcare expenditure
Category:Microbiology
Achille_Valenciennes
Emotional_dysregulation
Category:Antidepressants
Serum_protein_electrophoresis
